Skip to content

Perceptual Distortions in Acute Neck Pain

Perceptual Distortions in Acute Neck Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03495076
Enrollment
30
Registered
2018-04-11
Start date
2018-04-20
Completion date
2018-07-20
Last updated
2018-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain, Posterior, Pain, Acute

Keywords

Tactile acuity, Tactile dysfunction, Sensory dissociation, Two-point discrimination, Perception

Brief summary

Research has shown that chronic pain is related to variety of perceptual distortions. Little is known on how acute pain experience influences perception, especially precision of touch. This project is aiming to test the hypothesis of pain as a process of biological value leading to improvement in tactile acuity.

Detailed description

This project has following goals: 1. To test the hypothesis of pain as a process of biological value leading to improvement in tactile acuity 2. To investigate intra-rater reliability of tests measuring perceptual distortions in pain 3. To investigate validity of novel tests measuring perceptual distortions in pain 4. To explore the influence of acute neck pain on left/right recognition task 5. To explore the effect of acute neck pain on body perception

Interventions

OTHERSaline injection

In the saline injection condition, acute neck pain will be induced via 0.5 ml hypertonic (5% NaCl) saline bolus injection which is a commonly used model of acute pain. Saline will be injected into the right (or left) trapezius muscle at the level of C7 cervical level. Injections will be performed by a physician under ultrasound imaging guidance to ensure that each single injection will be equally placed at the same depth. The side for the pain induction will be randomised across subjects. The place of needle insertion and corresponding point on the opposite side of the body will be covered by placing a small piece of adhesive plaster to ensure blinding.

OTHERSham injection

In the sham-injection condition (nocebo comparator), a real needle will be shown to the participants to imitate and produce the anticipation of a pain experience. A pinprick sensation will be produced by a weighted stimulus applied perpendicularly to the skin without piercing the skin. A stimulus of 512 millinewtons (mN) will be used to produce a pinprick sensation and activation of cutaneous nociceptors. Adhesive tapes covering stimulation points will also be provided. The stimuli will be applied in exactly the same spot as the real injection in previous experimental condition.

Sponsors

University of Luebeck
CollaboratorOTHER
The Jerzy Kukuczka Academy of Physical Education in Katowice
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants will not be informed about the hypotheses tested and will not be informed about the sham-injection condition. The fact that they received only one injection during the study period will be uncovered at the end of the project. Examiner will be blinded towards conditions sequence. Between pre-test and post-test examiner will not be present in the research room to provide blinding towards the manipulation provided (control, saline injection, sham injection).

Intervention model description

Within-group designed study. All participants will be assessed in three different experimental conditions (control, saline injection, sham injection). The order of conditions will be counterbalanced across participants and randomly chosen.

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Only participants without tactile dysfunction will be included. * Participants reporting availability during the days in which the research will be performed.

Exclusion criteria

* current pain experience * episodes of neck * thoracic or lumbar pain lasting more than 24 hours within previous month * history of chronic pain, i.e. pain lasting more than three-month period * comorbidities affecting nervous system * cardio-vascular diseases * psychiatric illnesses * any disease requiring systematic drug consumption * diagnosed scoliosis.

Design outcomes

Primary

MeasureTime frameDescription
Tactile acuity measured by two-point discrimination test (TPD).TPD change from baseline at 30 seconds post-manipulation period (e.g. saline injection).Mechanical callipers will be delicately applied to the spot just below the location where real or sham injection will be administered. Tactile stimuli will be applied until the very first blanching of the skin. Testing will be commenced with 0 mm between the two calliper's tips, and then the distance between them will be gradually increased until participants will able to verbally report that two points had been touched instead of one. Subsequently, the descending sequence will be applied until the perception of the two points disappeared.

Secondary

MeasureTime frameDescription
Laterality judgements measured by left/right recognition application.Measured at baseline and ~30 seconds after manipulation (e.g. saline injection).A set of images displaying human neck in different orientation in space will be show to participants. The goal of the task is to decide whether given picture depicts neck rotated to the left or right or flexed into left o right side. The accuracy and response time is measured.
Sensory dissociation measured by two-point estimation task (TPE).Measured at baseline and ~30 seconds after manipulation (e.g. saline injection).One tactile stimulus will be applied until the very first blanching of the skin, with a 120 mm horizontal separation between the calipers' tips. Participants will be then asked to indicate with their calipers the distance they have perceived.

Other

MeasureTime frameDescription
Fear of Pain Questionnaire (FPQ-III).Measured only at baseline.FPQ-III consists of three subscales measuring: minor pain, severe pain, and medical pain. Each subscale contains 10 items. The total score has a range 30-150. A higher score indicates greater fear of pain.
Pain intensity measured behaviourally on a Numerical Rating Scale (NRS).Pain intensity will be measured just after saline/sham injection and every 10 seconds after this time point up until 30 seconds.The scale for pain intensity ratings will range from 0 = no pain to 10 = the worst pain imaginable
Pain durationOne measurement collected immediately after pain alleviation. The time frame will vary from person to person, however it is expected to collect the data an average 10 minutes after the injection.Pain duration measured by physician in seconds.
Distribution of pain measured by estimating the diameter of the circle representing area affected by pain.Pain distribution will be measured just after saline/sham injection and every 10 seconds after this time point up until 30 seconds.Greater circle (diameter in cm) will refer to the greater distribution of pain (larger body surface affected).
Fear of pain measured on a Numerical Rating Scale (NRS)Fear of pain (state) measured only at baselineFear of pain will be rated on a scale ranging from 0 = not at all to 10 = very much.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026